A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision
Client green-lighted the development of the novel tool and incorporated platform specifications identified through DeciBio research. The novel tool was developed and looks promising in early access program studies with customer types prioritized by DeciBio research
~10 weeks ( Two-Phase Project)
U.S., Canada, EU
Research Tools
Pricing Strategy
Voice-Of-Customer Research